BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21866954)

  • 1. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
    Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
    Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
    Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
    Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
    Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
    Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
    Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The research on construction and expression of eukaryotic expression plasmid for a recombinant immunotoxin mMIP-1alpha-DT390].
    Lü ML; Li H; Liang WB; Chen WJ; Jia Y; Jiang ZH; Zhang WD; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):1-5. PubMed ID: 17294715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.
    Woo JH; Liu YY; Mathias A; Stavrou S; Wang Z; Thompson J; Neville DM
    Protein Expr Purif; 2002 Jul; 25(2):270-82. PubMed ID: 12135560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.
    Vallera DA; Panoskaltsis-Mortari A; Jost C; Ramakrishnan S; Eide CR; Kreitman RJ; Nicholls PJ; Pennell C; Blazar BR
    Blood; 1996 Sep; 88(6):2342-53. PubMed ID: 8822957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of recombinant soluble porcine CD3 ectodomain molecules: mapping the epitope of an anti-porcine CD3 monoclonal antibody 898H2-6-15.
    Peraino JS; Hermanrud CE; Springett L; Zhang H; Li G; Srinivasan S; Gusha A; Sachs DH; Huang CA; Wang Z
    Cell Immunol; 2012; 276(1-2):162-7. PubMed ID: 22672968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with immunotoxin.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.
    Wamala I; Matar AJ; Farkash E; Wang Z; Huang CA; Sachs DH
    Transpl Immunol; 2013 Dec; 29(1-4):60-3. PubMed ID: 24157659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin.
    Kim GB; Wang Z; Liu YY; Stavrou S; Mathias A; Goodwin KJ; Thomas JM; Neville DM
    Protein Eng Des Sel; 2007 Sep; 20(9):425-32. PubMed ID: 17693455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
    Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
    Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood.
    Thompson J; Hu H; Scharff J; Neville DM
    J Biol Chem; 1995 Nov; 270(47):28037-41. PubMed ID: 7499288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
    Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
    Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro.
    Meng G; Jiang Y; Hubbard W; Thomas JM
    Transpl Immunol; 1998 Mar; 6(1):53-9. PubMed ID: 9640629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathy in miniature swine after administration of the mutant diphtheria toxin-based immunotoxin, pCD3-CRM9.
    Gargollo P; Yamada K; Esnaola N; Fuchimoto Y; Newell KL; Sachs DH; Huang CA
    Transplantation; 2001 Sep; 72(5):818-22. PubMed ID: 11571443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin.
    Peraino JS; Schenk M; Zhang H; Li G; Hermanrud CE; Neville DM; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
    J Immunol Methods; 2013 May; 391(1-2):103-11. PubMed ID: 23470981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
    Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.